Target intelligence / Profile preview

Ribosomal protein L17 pseudogene (None in widespread use)

Target
None in widespread use
Molecular classification
Other, Processed pseudogene
01

Overview

Ribosomal protein L17 pseudogenes are DNA sequences in the human genome that share high sequence similarity with the functional ribosomal protein L17 gene but have lost protein-coding capability through mutations or truncations. Processed pseudogenes like these are generally considered molecular fossils, typically nonfunctional and not transcribed, although rare regulatory functions for some pseudogenes have been hypothesized. There are dozens of distinct ribosomal protein L17 pseudogene loci in the genome, none of which encode a functional ribosomal protein. These pseudogenes are not considered therapeutic targets, nor are they implicated in disease or drug interactions. The true, protein-coding therapeutic target is ribosomal protein L17 (RPL17), not its pseudogenes.

Other names
RPL17 pseudogeneRPL17P
02

Mechanism of action

None (no mechanism of action due to lack of protein product or function)

03

Biological functions

None (does not encode functional protein)Generally regarded as nonfunctional (though some pseudogenes may have regulatory RNA roles in rare cases)
04

Disease associations

None known (does not participate in disease etiology directly)
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None established

Beyond the preview

Go deeper on Ribosomal protein L17 pseudogene (None in widespread use).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L17 pseudogene (None in widespread use).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call